Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-life experience after 3 months with tezepelumab before marketing approval.
Violán VV, Cano BG, Casero MÁR, González-Mancebo E, Vicente EM, Trujillo MJT, Gandolfo-Cano M. Violán VV, et al. Among authors: gandolfo cano m. Allergol Immunopathol (Madr). 2024 Mar 1;52(2):80-82. doi: 10.15586/aei.v52i2.1063. eCollection 2024. Allergol Immunopathol (Madr). 2024. PMID: 38459894
[Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality].
Blanco-Aparicio M, Almonacid C, Calvín Lamas M, Delgado J, Gandolfo-Cano M, López-Carrasco V, Vega JM, Díaz-Pérez D, Villamañán E. Blanco-Aparicio M, et al. Among authors: gandolfo cano m. Open Respir Arch. 2023 Mar 17;5(3):100239. doi: 10.1016/j.opresp.2023.100239. eCollection 2023 Jul-Sep. Open Respir Arch. 2023. PMID: 37810420 Free PMC article. Review. Spanish.
Safety and efficacy of benralizumab in elderly subjects with severe asthma.
Valverde-Monge M, Cárdenas R, García-Moguel I, Rosado A, Gandolfo-Cano M, Echarren TR, Moro-Moro MDM, Reaño Martos MDM, Pineda-Pineda R, Arroba CM, Domínguez-Ortega J; AIRE Group. Valverde-Monge M, et al. Among authors: gandolfo cano m. J Asthma. 2024 Mar;61(3):232-237. doi: 10.1080/02770903.2023.2263078. Epub 2024 Feb 8. J Asthma. 2024. PMID: 37737844
Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab.
González-Cano B, Villalobos-Violán V, Gandolfo-Cano M, Trujillo-Trujillo MJ, Mohedano-Vicente E, González-Mancebo E. González-Cano B, et al. Among authors: gandolfo cano m. J Allergy Clin Immunol Pract. 2023 Aug;11(8):2614-2615. doi: 10.1016/j.jaip.2023.05.008. Epub 2023 May 16. J Allergy Clin Immunol Pract. 2023. PMID: 37196918 No abstract available.
Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study.
García-Moguel I, Rosado A, Gómez-Cardeñosa A, Gandolfo-Cano M, Robledo Echarren T, Moro Moro MDM, Reaño Martos MDM, Pineda-Pineda R, Valverde-Monge M, Martin-Arriscado Arroba C, Domínguez-Ortega J; AIRE Group. García-Moguel I, et al. Among authors: gandolfo cano m. J Asthma Allergy. 2022 May 13;15:623-632. doi: 10.2147/JAA.S358738. eCollection 2022. J Asthma Allergy. 2022. PMID: 35592384 Free PMC article.
COVID-19 Course in Allergic Asthma Patients: A Spanish Cohort Analysis.
Habernau Mena A, García-Moguel I, Vazquez de la Torre Gaspar M, Mugica V, Alvarado Izquierdo MI, Jimenez Blanco MA, Gandolfo-Cano M, Jiménez Lara M, Gonzalez Moreno A, Saura Foix P, Navarro-Pulido A, Martin-Arriscado Arroba C, Delgado Romero J, Dominguez-Ortega J; Asthma Committee of SOCIEDAD ESPAÑOLA DE ALERGOLOGÍA E INMUNOLOGÍA CLÍNICA (SEAIC). Habernau Mena A, et al. Among authors: gandolfo cano m. J Asthma Allergy. 2022 Feb 22;15:257-264. doi: 10.2147/JAA.S344934. eCollection 2022. J Asthma Allergy. 2022. PMID: 35228805 Free PMC article.
Hypersensitivity Reactions to Cancer Chemotherapy: Practical Recommendations of ARADyAL for Diagnosis and Desensitization.
Vega A, Jimenez-Rodriguez TW, Barranco R, Bartra J, Diéguez MC, Doña I, Fernández-Rivas M, Gandolfo-Cano M, Gastaminza-Lasarte G, González-Mancebo E, de la Hoz Caballer B, Sánchez-Morillas L, Torres MJ, Berges-Gimeno MP, Muñoz-Cano R. Vega A, et al. Among authors: gandolfo cano m. J Investig Allergol Clin Immunol. 2021 Oct 25;31(5):364-384. doi: 10.18176/jiaci.0712. Epub 2021 May 28. J Investig Allergol Clin Immunol. 2021. PMID: 34045179 Free article. Review.
Management of hypersensitivity reactions to chemotherapy and biologic agents: A survey of ARADyAL (Asthma, Adverse Drug Reactions and Allergy Network) Spanish allergy services.
Jimenez-Rodriguez TW, Berges-Gimeno MP, Barranco R, Bartra J, Diéguez MDC, Doña I, Fernández-Rivas M, Gandolfo-Cano MDM, Gastaminza-Lasarte G, González-Mancebo E, de la Hoz Caballer B, Sánchez-Morillas L, Torres MJ, Vega A, Muñoz-Cano R. Jimenez-Rodriguez TW, et al. Among authors: gandolfo cano mdm. Allergy. 2021 Jul;76(7):2249-2253. doi: 10.1111/all.14743. Epub 2021 Feb 27. Allergy. 2021. PMID: 33476405 No abstract available.
Vulvovaginitis and dog allergy.
Gandolfo-Cano M, González-Mancebo E, Rincón-Olbés P, González-de-Olano D. Gandolfo-Cano M, et al. Semergen. 2020 May-Jun;46(4):283-284. doi: 10.1016/j.semerg.2019.11.010. Epub 2020 Feb 20. Semergen. 2020. PMID: 32089402 No abstract available.
37 results